Sejong Medical세종메디칼
258830 · KOSDAQ · ₩258830 · 세종메디칼
₩412 ₩0 (0.00%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩18B | ₩17B | ₩17B | ₩16B | ₩15B |
| Cost of sales | ₩7.8B | ₩7.7B | ₩8.5B | ₩7.9B | ₩7.1B |
| Gross profit | ₩11B | ₩9.3B | ₩9B | ₩8.2B | ₩7.9B |
| Operating income | ₩2.6B | ₩1.2B | ₩2.8B | −₩1.8B | −₩676M |
| Net income | ₩549M | −₩64B | −₩18B | −₩97B | −₩3B |
| Net income to shareholders | ₩549M | −₩64B | −₩18B | −₩97B | −₩3B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩54B | ₩46B | ₩108B | ₩138B | ₩91B |
| Current assets | ₩18B | ₩15B | ₩11B | ₩42B | ₩47B |
| Cash and equivalents | ₩7B | ₩7.1B | ₩3.1B | ₩2.7B | ₩22B |
| Total liabilities | ₩28B | ₩22B | ₩90B | ₩112B | ₩35B |
| Current liabilities | ₩25B | ₩7B | ₩81B | ₩111B | ₩6.2B |
| Borrowings | ₩5.2B | ₩15B | ₩68B | ₩80B | ₩30B |
| Total equity | ₩26B | ₩24B | ₩11B | ₩27B | ₩55B |
| Shareholders' equity | ₩26B | ₩24B | ₩11B | ₩27B | ₩55B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩2.5B | ₩3.3B | ₩3.7B | −₩429M | ₩1B |
| Capital spending | ₩8.5B | ₩4.1B | ₩1.9B | ₩885M | ₩4.6B |
| Free cash flow | −₩6.1B | −₩855M | ₩1.7B | −₩1.3B | −₩3.5B |
| Dividends paid | — | — | — | — | ₩646M |
Consolidated where available. Amounts in won.
Also known as: Sejong Medical / 세종메디칼 / 258830 / KRX:258830
Source: KRX statistical information